blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP Citations: EP3261663

Cited inSearch
Type:Patent literature
Publication No.:EP1801123  [IY]
 (ALTUS PHARMACEUTICALS INC et al.) [I] 1-19 * See e.g. figures 1-6; examples 6, 26, 28, 31, 32, 34 and 37; paragraphs [0177] - [0185] and [0188] *[Y] 1-19
Type:Patent literature
Publication No.:WO2006133486  [Y]
 (MACFARLANE BURNET INST FOR MED et al.) [Y] 1-19 * See e.g. the abstract *
Type:Non-patent literature
Publication information:[IY]   SAPHIRE ERICA OLLMANN ET AL: "Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: An antibody that broadly neutralizes primary isolates of HIV-1", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY, MUNKSGAARD PUBLISHERS LTD. COPENHAGEN, DK, vol. 57, no. 1, 1 January 2001 (2001-01-01), pages 168 - 171, XP002452899, ISSN: 0907-4449, DOI: 10.1107/S0907444900017376 [I] 1-19 * See e.g. the abstract; section 2.2. "Crystallization" on page 169, right column, second paragraph; page 169, right column, third paragraph * [Y] 1-19
DOI: http://dx.doi.org/10.1107/S0907444900017376
Type:Non-patent literature
Publication information:[IY]   OLLMANN SAPHIRE E ET AL: "Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 293, no. 5532, 10 August 2001 (2001-08-10), pages 1155 - 1159, XP002338502, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.1061692 [I] 1-19 * See page 1155, most right column, beginning of second paragraph * [Y] 1-19
DOI: http://dx.doi.org/10.1126/science.1061692
Type:Non-patent literature
Publication information:[IY]   HARRIS LISA J ET AL: "Refined structure of an intact IgG2a monoclonal antibody", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 36, no. 7, 1 January 1997 (1997-01-01), pages 1581 - 1597, XP009506517, ISSN: 0006-2960, DOI: 10.1021/BI962514+ [I] 1-19 * See e.g. page 1582, left column, second paragraph * [Y] 1-19
DOI: http://dx.doi.org/10.1021/bi962514+
Type:Non-patent literature
Publication information:[IY]   HARRIS L J ET AL: "Crystallographic structure of an intact IgG1 monoclonal antibody", JOURNAL OF MOLECULAR BIO, ACADEMIC PRESS, UNITED KINGDOM, vol. 275, no. 5, 6 February 1998 (1998-02-06), pages 861 - 872, XP004461446, ISSN: 0022-2836, DOI: 10.1006/JMBI.1997.1508 [I] 1-19 * See e.g. the abstract; the line bridging left and right columns on page 869 *[Y] 1-19
DOI: http://dx.doi.org/10.1006/jmbi.1997.1508
Type:Non-patent literature
Publication information:[IY]   HARRIS L J ET AL: "CRYSTALLIZATION OF INTACT MONOCLONAL ANTIBODIES", PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS, JOHN WILEY & SONS, INC, US, vol. 23, no. 2, 1 October 1995 (1995-10-01), pages 285 - 289, XP001098112, ISSN: 0887-3585, DOI: 10.1002/PROT.340230218 [I] 1-19 * See e.g. the abstract; page 286, left column, fourth paragraph *[Y] 1-19
DOI: http://dx.doi.org/10.1002/prot.340230218
Type:Non-patent literature
Publication information:[Y]   SHARMA SADHANA ET AL: "Preparation, purification and crystallization of antibody Fabs and single-chain Fv domains", 1 January 1997, IMMUNOLOGY METHODS MANUAL : THE COMPREHENSIVE SOURCEBOOK OF TECHNIQUES, SAN DIEGO [U.A.] : ACAD. PRESS, 1997, US, PAGE(S) 15 - 37, ISBN: 978-0-12-442711-2, XP009506515 [Y] 1-19 * See e.g. pages 32 to 34 for general teachings about crystallization of antibody Fabs and single-chain Fv domains *
Type:Non-patent literature
Publication information:[IY]   HARRIS L J ET AL: "COMPARISON OF THE CONFORMATIONS OF TWO INTACT MONOCLONAL ANTIBODIES WITH HINGES", IMMUNOLOGICAL REVI, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 163, 1 June 1998 (1998-06-01), pages 35 - 43, XP009056421, ISSN: 0105-2896, DOI: 10.1111/J.1600-065X.1998.TB01186.X [I] 1-19 * See e.g. page 35, first paragraph of the introduction *[Y] 1-19
DOI: http://dx.doi.org/10.1111/j.1600-065X.1998.tb01186.x
Type:Non-patent literature
Publication information:[PX]   SCAPIN GIOVANNA ET AL: "Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab", NATURE STRUCTURAL & MOLECULAR BIOLOGY, NATURE PUBLISHING GROUP, US, vol. 22, no. 12, 1 December 2015 (2015-12-01), pages 953 - 958, XP002766296, ISSN: 1545-9985, DOI: 10.1038/NSMB.3129 [PX] 1-19 * The whole document. This is the publication of the invention, co-authored by the inventors *
DOI: http://dx.doi.org/10.1038/nsmb.3129
Cited inInternational search
Type:Patent literature
Publication No.:WO2016024228  [P, A]
 (ACERTA PHARMA BV et al.) [P, A] 1-4, 6-9, 12-20 * entire document *
Type:Patent literature
Publication No.:US2014314714  [A]
 (HONJO TASUKU et al.) [A] 1-4, 6-9, 12-20 * entire document *
Type:Patent literature
Publication No.:US2014348841  [A]
 (SCHEBYE XIAO MIN et al.) [A] 1-4, 6-9, 12-20 * entire document *
Type:Patent literature
Publication No.:US2013108651  [A]
 (CARVEN GREGORY JOHN et al.) [A] 1-4, 6-9, 12-20 * entire document *
Type:Patent literature
Publication No.:WO2015011199  [A]
 (NOVALIQ GMBH et al.) [A] 1-4, 6-9, 12-20 * entire document *
Type:Patent literature
Publication No.:CA2918888  [A]
 (ONO PHARMACEUTICAL CO et al.) [A] 1-4, 6-9, 12-20 * entire document *
Type:Patent literature
Publication No.:US2014234296  [A]
 (SHARMA MANOJ K et al.) [A] 1-4, 6-9, 12-20 * entire document *
Cited inExamination
Type:Patent literature
Publication No.:WO02102303  
Type:Patent literature
Publication No.:US7960516  
Type:Patent literature
Publication No.:WO2008121301  
Type:Non-patent literature
Publication information:  ABRAHAMS GABRIEL JAN ET AL: "BLAST ing away preconceptions in crystallization trials", ACTA CRYSTALLOGRAPHICA SECTION F STRUCTURAL BIOLOGY COMMUNICATIONS, vol. 75, no. 3, 4 January 2019 (2019-01-04), pages 184 - 192, XP55792250, DOI: 10.1107/S2053230X19000141 [Y] 1-19
Type:Non-patent literature
Publication information:  OMID HAMID ET AL: "Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma", NEW ENGLAND JOURNAL OF MEDICINE, vol. 369, no. 2, 11 July 2013 (2013-07-11), pages 134 - 144, XP055182016, ISSN: 0028-4793, DOI: 10.1056/NEJMoa1305133 [I] 1-19 * See e.g. the abstract; section 2.2. "Crystallization" on page 169, right column, second paragraph; page 169, right column, third paragraph *[Y] 1-19
DOI: http://dx.doi.org/10.1056/NEJMoa1305133
Cited inby applicant
Type:Patent literature
Publication No.:WO2012135408  
Type:Patent literature
Publication No.:US7833525  
Type:Patent literature
Publication No.:WO2012135035  
Type:Patent literature
Publication No.:WO02072636  
Type:Patent literature
Publication No.:WO2005121177  
Type:Patent literature
Publication No.:WO2008057240  
Type:Patent literature
Publication No.:WO2014004436  
Type:Patent literature
Publication No.:US4816567  
Type:Non-patent literature
Publication information:  YANG, M.X. ET AL., PROC. NAT'L. ACAD. SCI.(USA), vol. 100, 2003, pages 6934 - 1939
Type:Non-patent literature
Publication information:  BASU, S.K. ET AL., EXPERT OPIN. BIOL. THERA., vol. 4, 2004, pages 301 - 317
Type:Non-patent literature
Publication information:  CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 3242
Type:Non-patent literature
Publication information:  KABAT, ADV. PROT. CHEM., vol. 32, 1978, pages 1 - 75
Type:Non-patent literature
Publication information:  KABAT ET AL., J. BIOL. CHEM., vol. 252, 1977, pages 6609 - 6616
Type:Non-patent literature
Publication information:  CHOTHIA ET AL., J MOL. BIOL., vol. 196, 1987, pages 901 - 917
Type:Non-patent literature
Publication information:  CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 878 - 883
Type:Non-patent literature
Publication information:  KOHLER ET AL., NATURE, vol. 256, 1975, pages 495
Type:Non-patent literature
Publication information:  MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597
Type:Non-patent literature
Publication information:  PRESTA, J. ALLERGY CLIN. IMMUNOL., vol. 116, 2005, pages 731
Type:Non-patent literature
Publication information:  THOMPSON, R. H. ET AL., PNAS, vol. 101, no. 49, 2004, pages 17174 - 17179
Type:Non-patent literature
Publication information:  THOMPSON, R. H. ET AL., CANCER RES., vol. 66, 2006, pages 3381 - 3385
Type:Non-patent literature
Publication information:  GADIOT, J. ET AL., CANCER, vol. 117, 2011, pages 2192 - 2201
Type:Non-patent literature
Publication information:  TAUBE, J. M. ET AL., SCI TRANSL MED, vol. 4, 2012, pages 127ra37
Type:Non-patent literature
Publication information:  TOPLIAN, S. L. ET AL., NEW ENG. JMED., vol. 366, no. 26, 2012, pages 2443 - 2454
Type:Non-patent literature
Publication information:  WHO DRUG INFORMATION, vol. 27, no. 2, 2013, pages 161 - 162
Type:Non-patent literature
Publication information:  W. A. WEBER, J. NUCL. MED., vol. 50, 2009, pages 1S - 10S
Type:Non-patent literature
Publication information:  GIEGE ET AL., ACTA CRYSTALLOGR, vol. D50, 1994, pages 339
Type:Non-patent literature
Publication information:  MCPHERSON, EUR. J. BIOCHEM., vol. 189, 1990, pages 1
Type:Non-patent literature
Publication information:  MCPHERSON, J. BIOL. CHEM., vol. 251, 1976, pages 6300
Type:Non-patent literature
Publication information:  "Remington's Pharmaceutical Sciences and U.S. Pharmacopeia:National Formulary", 1984, MACK PUBLISHING COMPANY
Type:Non-patent literature
Publication information:  VONRHEIN C. ET AL., ACTA CRYST., vol. D67, 2011, pages 293 - 302
Type:Non-patent literature
Publication information:  MCCOY A.J. ET AL., J. APPL. CRYST., vol. 40, 2007, pages 658 - 674
Type:Non-patent literature
Publication information:  DAVIES A.M. ET AL., J. MOL. BIOL., vol. 426, no. 3, 2014, pages 630 - 644
Type:Non-patent literature
Publication information:  MURSHUDOV G.N. ET AL., ACTA CRYSTALL., vol. D53, 1997, pages 240 - 25
Type:Non-patent literature
Publication information:  BRICOGNE G ET AL., BUSTER, 2011
Type:Non-patent literature
Publication information:  EMSLEY P ET AL., ACTA CRYST., vol. D66, 2010, pages 486 - 501
Cited inother
Type:Patent literature
Publication No.:WO02102303  
Type:Patent literature
Publication No.:US7960516  
Type:Patent literature
Publication No.:WO2008121301  
Type:Non-patent literature
Publication information:  OMID HAMID, CAROLINE ROBERT, ADIL DAUD, F. STEPHEN HODI, WEN-JEN HWU, RICHARD KEFFORD, JEDD D. WOLCHOK, PETER HERSEY, RICHARD W. J: "Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma", NEW ENGLAND JOURNAL OF MEDICINE, NEW ENGLAND JOURNAL OF MEDICINE, vol. 369, no. 2, 11 July 2013 (2013-07-11), pages 134 - 144, XP055182016, ISSN: 00284793, DOI: 10.1056/NEJMoa1305133
DOI: http://dx.doi.org/10.1056/NEJMoa1305133